Sonia Escaich

1.4k total citations
32 papers, 1.1k citations indexed

About

Sonia Escaich is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Sonia Escaich has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 14 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Sonia Escaich's work include HIV Research and Treatment (15 papers), Virus-based gene therapy research (6 papers) and Antibiotic Resistance in Bacteria (6 papers). Sonia Escaich is often cited by papers focused on HIV Research and Treatment (15 papers), Virus-based gene therapy research (6 papers) and Antibiotic Resistance in Bacteria (6 papers). Sonia Escaich collaborates with scholars based in France, United States and Belgium. Sonia Escaich's co-authors include Ernst Böhnlein, Vanida Vongsouthi, F. Moreau, Lionel Durant, Ivan Plavec, Vincent Gerusz, Alexis Denis, Hideto Kaneshima, Stéphanie Floquet and Mark Bonyhadi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Sonia Escaich

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonia Escaich France 22 514 331 259 242 210 32 1.1k
Daniel D. Long United States 22 906 1.8× 98 0.3× 314 1.2× 515 2.1× 436 2.1× 45 1.7k
Robert Naso United States 17 635 1.2× 100 0.3× 597 2.3× 161 0.7× 92 0.4× 27 1.4k
Nicolas Mouz France 14 385 0.7× 179 0.5× 298 1.2× 150 0.6× 45 0.2× 23 1.1k
Jason Munguia United States 8 259 0.5× 150 0.5× 110 0.4× 66 0.3× 27 0.1× 10 617
Catherine Guerreiro France 26 970 1.9× 389 1.2× 766 3.0× 35 0.1× 563 2.7× 53 1.7k
Patrick K. Martin United States 13 644 1.3× 49 0.1× 179 0.7× 137 0.6× 48 0.2× 14 958
Gavan Holloway Australia 16 252 0.5× 159 0.5× 644 2.5× 192 0.8× 35 0.2× 26 1.1k
Martine Braibant France 20 405 0.8× 444 1.3× 785 3.0× 118 0.5× 25 0.1× 44 1.3k
Neelima Sukumar United States 12 303 0.6× 102 0.3× 368 1.4× 116 0.5× 21 0.1× 15 798
Laurence A. Mulard France 27 1.2k 2.4× 150 0.5× 582 2.2× 55 0.2× 901 4.3× 93 2.2k

Countries citing papers authored by Sonia Escaich

Since Specialization
Citations

This map shows the geographic impact of Sonia Escaich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Escaich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Escaich more than expected).

Fields of papers citing papers by Sonia Escaich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Escaich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Escaich. The network helps show where Sonia Escaich may publish in the future.

Co-authorship network of co-authors of Sonia Escaich

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Escaich. A scholar is included among the top collaborators of Sonia Escaich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Escaich. Sonia Escaich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Desroy, Nicolas, Alexis Denis, Dmytro Atamanyuk, et al.. (2013). Novel HldE-K Inhibitors Leading to Attenuated Gram Negative Bacterial Virulence. Journal of Medicinal Chemistry. 56(4). 1418–1430. 23 indexed citations
3.
Escaich, Sonia. (2010). Novel agents to inhibit microbial virulence and pathogenicity. Expert Opinion on Therapeutic Patents. 20(10). 1401–1418. 43 indexed citations
4.
Escaich, Sonia. (2008). MUT37307 FabI Inhibitor: In Vitro and In Vivo Antibacterial Activity against S. aureus. 46th Annual Meeting. 1 indexed citations
5.
Escaich, Sonia. (2008). MUT37307 A Novel Antibacterial Against Methicillin Resistant Staphylococci. 46th Annual Meeting. 1 indexed citations
6.
Desroy, Nicolas, F. Moreau, Stéphanie Floquet, et al.. (2008). Towards Gram-negative antivirulence drugs: New inhibitors of HldE kinase. Bioorganic & Medicinal Chemistry. 17(3). 1276–1289. 66 indexed citations
7.
Dohi, Hirofumi, Maxime Durka, Michaël Bosco, et al.. (2008). Stereoselective Glycal Fluorophosphorylation: Synthesis of ADP‐2‐fluoroheptose, an Inhibitor of the LPS Biosynthesis. Chemistry - A European Journal. 14(31). 9530–9539. 36 indexed citations
8.
Moreau, F., Nicolas Desroy, Vanida Vongsouthi, et al.. (2008). Discovery of new Gram-negative antivirulence drugs: Structure and properties of novel E. coli WaaC inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 4022–4026. 72 indexed citations
9.
Escaich, Sonia. (2008). Antivirulence as a new antibacterial approach for chemotherapy. Current Opinion in Chemical Biology. 12(4). 400–408. 142 indexed citations
10.
Grizot, Sylvestre, Vanida Vongsouthi, F. Moreau, et al.. (2006). Structure of the Escherichia coli Heptosyltransferase WaaC: Binary Complexes with ADP AND ADP-2-deoxy-2-fluoro Heptose. Journal of Molecular Biology. 363(2). 383–394. 69 indexed citations
11.
Durant, Lionel, et al.. (2006). Identification of Candidates for a Subunit Vaccine against Extraintestinal Pathogenic Escherichia coli. Infection and Immunity. 75(4). 1916–1925. 47 indexed citations
12.
Druillennec, Sabine, Sonia Escaich, Nohad Gresh, et al.. (1999). HIV‐1ヌクレオカプシド蛋白質模倣体は逆転写を阻害し,抗ウイルス活性を示す. Proc Natl Acad Sci USA. 96(9). 4886–4891. 19 indexed citations
13.
Plavec, Ivan, Manju Agarwal, Marbin Pineda, et al.. (1997). High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS. Gene Therapy. 4(2). 128–139. 64 indexed citations
14.
Junker, U., Dorian Bevec, Carmen Barske, et al.. (1996). Intracellular Expression of Cellular eIF-5A Mutants Inhibits HIV-1 Replication in Human T Cells: A Feasibility Study. Human Gene Therapy. 7(15). 1861–1869. 28 indexed citations
15.
Plavec, Ivan, et al.. (1996). Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells.. PubMed. 3(8). 717–24. 25 indexed citations
16.
Rigg, Richard, et al.. (1995). Detection of intracellular HIV-1 Rev protein by flow cytometry. Journal of Immunological Methods. 188(2). 187–195. 17 indexed citations
17.
Escaich, Sonia, et al.. (1992). Relevance of the Quantitative Detection of HIV Proviral Sequences in PBMC of Infected Individuals. AIDS Research and Human Retroviruses. 8(10). 1833–1837. 23 indexed citations
18.
Kanitakis, Jean, Sonia Escaich, Christian Trépo, & J Thivolet. (1991). Detection of Human Immunodeficiency Virus-DNA and RNA in the Skin of HIV-Infected Patients Using the Polymerase Chain Reaction. Journal of Investigative Dermatology. 97(1). 91–96. 37 indexed citations
19.
Escaich, Sonia, et al.. (1991). Plasma viraemia as a marker of viral replication in HIV-infected individuals. AIDS. 5(10). 1189–1194. 28 indexed citations
20.
Vermot‐Desroches, Claudine, D. Rigal, Sonia Escaich, et al.. (1991). Functional Epitope Analysis of the Human CD 11 a/CD 18 Molecule (LFA‐1, Lymphocyte Function‐Associated Antigen 1) Involved in HIV‐1‐Induced Syncytium Formation. Scandinavian Journal of Immunology. 34(4). 461–470. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel D. Long Breakdown of academic impact, for papers by Robert Naso Breakdown of academic impact, for papers by Nicolas Mouz Breakdown of academic impact, for papers by Jason Munguia Breakdown of academic impact, for papers by Catherine Guerreiro Breakdown of academic impact, for papers by Patrick K. Martin Breakdown of academic impact, for papers by Gavan Holloway Breakdown of academic impact, for papers by Martine Braibant Breakdown of academic impact, for papers by Neelima Sukumar Breakdown of academic impact, for papers by Laurence A. Mulard
Rankless by CCL
2026